<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://regulatorynews.com/baxter-round-lake-warning-letter</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T05:58:49-04:00</news:publication_date>
      <news:title>FDA Warns Baxter Over Repeat Sterile-Plant Failures</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/pfizer-talzenna-xtandi-mhspc-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T05:58:49-04:00</news:publication_date>
      <news:title>FDA Expands Talzenna-Xtandi to Earlier Prostate Cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/awiqli-pediatric-icodec-physicians</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T10:48:52-04:00</news:publication_date>
      <news:title>FDA Extends Once-Weekly Awiqli to Pediatric T2D</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/zydus-climara-pro-generic-physicians</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T10:48:52-04:00</news:publication_date>
      <news:title>FDA Approves First Generic Combined Menopause Patch</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/cosette-evoxac-oral-solution-nda-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T10:03:12-04:00</news:publication_date>
      <news:title>Cosette Earns Its First FDA Drug Approval With EVOXAC</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/fda-individualized-genome-editing-guidance</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T06:02:49-04:00</news:publication_date>
      <news:title>FDA Drafts a Path to One BLA Per Gene-Editing Family</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/mhra-icotrokinra-icotyde-psoriasis-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T06:02:49-04:00</news:publication_date>
      <news:title>MHRA Clears First Oral IL-23 Pill for Psoriasis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/sekisui-osom-covid-flu-combo-fda-clearance</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T06:02:49-04:00</news:publication_date>
      <news:title>FDA Clears Sekisui&apos;s OSOM COVID-19/Flu Combo Test</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/edwards-pascal-precision-tricuspid-physicians</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-27T11:17:16-04:00</news:publication_date>
      <news:title>FDA Approves Second Device for Tricuspid Repair</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/elucid-bioimaging-ffr-iq-fda-clearance</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-27T10:28:53-04:00</news:publication_date>
      <news:title>Elucid Wins FDA Clearance for Its FFR-IQ Software</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/lucid-diagnostics-esoguard-medicare-reimbursement</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-27T10:28:53-04:00</news:publication_date>
      <news:title>Lucid Begins Medicare Payment for EsoGuard DNA Test</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/sumitomo-enzomenib-breakthrough-therapy-designation</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-27T10:28:53-04:00</news:publication_date>
      <news:title>Sumitomo Earns FDA Breakthrough Tag for Enzomenib</news:title>
    </news:news>
  </url>
</urlset>
